Delivery Order SPE2DB22D2007-SPE2DB24FJ1CQ
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,389,740 units of Sandostatin LAR Depot 20 mg pharmaceutical kits. The $9,741.90 firm fixed price contract has an ultimate completion date of April 25, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 30 mg kits of the pharmaceutical product Sandostatin LAR Depot. The $6,562.82 award has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA, which serves as the primary vehicle for the company to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,648.30 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of Sandostatin LAR Depot, a specialty pharmaceutical product, with a completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,093.99 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 10 mg pharmaceutical kits. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,914.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 30 mg kits. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 and in effect through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $5,296.62 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Sandostatin LAR Depot 20 mg kits. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- This delivery order award, valued at $27,818.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg Kits. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen, as a major pharmaceutical distributor, holds multiple indefinite delivery contracts (IDCs) with DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities....
- The Defense Logistics Agency awarded a delivery order valued at $12,251.22 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits on December 29, 2025, with an ultimate completion date of December 30, 2025. This contract employs firm fixed pricing and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,061.38, is a delivery order for Sandostatin LAR Depot 20 mg kits. The contract has a final completion date of March 28, 2025 and utilizes a firm fixed price pricing structure. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen holds a significant...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide SANDOSTATIN LAR DEPOT 30 MG KTS pharmaceutical products. This $3,914.52 contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical and medical supplies to government agencies, particularly the...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ1CQDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,631.34 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Sandostatin LAR Depot 10 mg kits. This delivery order contract has an ultimate completion date of April 3, 2024 and was awarded on April 2, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999, to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. This IDC serves as the primary contract vehicle for AmerisourceBergen to provide these critical healthcare materials to the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 4/2/24 |